2024 Q3 Form 10-Q Financial Statement
#000162828024036502 Filed on August 09, 2024
Income Statement
| Concept | 2024 Q3 | 2024 Q2 |
|---|---|---|
| Revenue | $35.32M | $33.70M |
| YoY Change | 10.69% | 6.19% |
| Cost Of Revenue | $16.28M | $17.03M |
| YoY Change | 3.91% | 11.36% |
| Gross Profit | $19.05M | $16.67M |
| YoY Change | 17.23% | 1.37% |
| Gross Profit Margin | 53.92% | 49.46% |
| Selling, General & Admin | $15.53M | $14.57M |
| YoY Change | 7.34% | -2.98% |
| % of Gross Profit | 81.55% | 87.39% |
| Research & Development | ||
| YoY Change | ||
| % of Gross Profit | ||
| Depreciation & Amortization | $3.145M | $3.033M |
| YoY Change | 2.51% | -1.94% |
| % of Gross Profit | 16.51% | 18.2% |
| Operating Expenses | $15.78M | $14.81M |
| YoY Change | 8.46% | -2.51% |
| Operating Profit | $3.265M | $1.855M |
| YoY Change | 92.4% | 48.64% |
| Interest Expense | -$476.0K | -$484.0K |
| YoY Change | -184.55% | -178.06% |
| % of Operating Profit | -14.58% | -26.09% |
| Other Income/Expense, Net | -$4.000K | -$63.00K |
| YoY Change | -71.43% | -3250.0% |
| Pretax Income | $2.800M | $1.308M |
| YoY Change | 150.0% | 107.62% |
| Income Tax | $1.000M | $600.0K |
| % Of Pretax Income | 35.71% | 45.87% |
| Net Earnings | $1.807M | $717.0K |
| YoY Change | 162.26% | 64.83% |
| Net Earnings / Revenue | 5.12% | 2.13% |
| Basic Earnings Per Share | $0.08 | $0.03 |
| Diluted Earnings Per Share | $0.08 | $0.03 |
| COMMON SHARES | ||
| Basic Shares Outstanding | 21.32M shares | 21.26M shares |
| Diluted Shares Outstanding | 21.65M shares | 21.71M shares |
Balance Sheet
| Concept | 2024 Q3 | 2024 Q2 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $380.0K | $146.0K |
| YoY Change | 136.02% | 8.96% |
| Cash & Equivalents | $380.0K | $146.0K |
| Short-Term Investments | ||
| Other Short-Term Assets | $3.772M | $4.603M |
| YoY Change | -5.98% | 17.54% |
| Inventory | $6.700M | $6.839M |
| Prepaid Expenses | ||
| Receivables | $22.76M | $21.33M |
| Other Receivables | $0.00 | $0.00 |
| Total Short-Term Assets | $33.61M | $32.91M |
| YoY Change | 13.1% | 14.98% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $3.910M | $4.174M |
| YoY Change | -7.63% | -3.0% |
| Goodwill | $3.710M | $3.710M |
| YoY Change | 0.0% | 0.0% |
| Intangibles | $6.704M | $6.951M |
| YoY Change | -12.87% | -12.48% |
| Long-Term Investments | ||
| YoY Change | ||
| Other Assets | $1.009M | $1.334M |
| YoY Change | -42.7% | 8.99% |
| Total Long-Term Assets | $71.69M | $75.61M |
| YoY Change | -0.91% | 2.01% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $33.61M | $32.91M |
| Total Long-Term Assets | $71.69M | $75.61M |
| Total Assets | $105.3M | $108.5M |
| YoY Change | 3.17% | 5.62% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $8.908M | $9.940M |
| YoY Change | 16.76% | 81.35% |
| Accrued Expenses | ||
| YoY Change | ||
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | $0.00 | $0.00 |
| YoY Change | ||
| Total Short-Term Liabilities | $16.94M | $15.88M |
| YoY Change | 18.64% | 23.42% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $27.98M | $34.17M |
| YoY Change | -14.33% | -5.46% |
| Other Long-Term Liabilities | $4.879M | $4.995M |
| YoY Change | 32.87% | 31.93% |
| Total Long-Term Liabilities | $27.98M | $34.17M |
| YoY Change | -14.33% | -5.46% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $16.94M | $15.88M |
| Total Long-Term Liabilities | $27.98M | $34.17M |
| Total Liabilities | $49.79M | $55.04M |
| YoY Change | -1.6% | 4.26% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | -$58.19M | -$59.30M |
| YoY Change | -0.86% | -0.14% |
| Common Stock | $2.000K | $2.000K |
| YoY Change | 0.0% | 0.0% |
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $55.51M | $53.49M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $105.3M | $108.5M |
| YoY Change | 3.17% | 5.62% |
Cashflow Statement
| Concept | 2024 Q3 | 2024 Q2 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | $1.807M | $717.0K |
| YoY Change | 162.26% | 64.83% |
| Depreciation, Depletion And Amortization | $3.145M | $3.033M |
| YoY Change | 2.51% | -1.94% |
| Cash From Operating Activities | $9.842M | $2.309M |
| YoY Change | 130.82% | -5.83% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | $3.409M | $7.640M |
| YoY Change | 109.01% | 138.53% |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | $553.0K | $944.0K |
| YoY Change | -58.45% | 9.26% |
| Cash From Investing Activities | -$2.856M | -$6.696M |
| YoY Change | 852.0% | 186.28% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | ||
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | -6.752M | 3.711M |
| YoY Change | 71.5% | -1679.15% |
| NET CHANGE | ||
| Cash From Operating Activities | 9.842M | 2.309M |
| Cash From Investing Activities | -2.856M | -6.696M |
| Cash From Financing Activities | -6.752M | 3.711M |
| Net Change In Cash | 234.0K | -676.0K |
| YoY Change | 766.67% | 454.1% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | $9.842M | $2.309M |
| Capital Expenditures | $3.409M | $7.640M |
| Free Cash Flow | $6.433M | -$5.331M |
| YoY Change | 144.32% | 609.85% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2024Q2 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-1000 | usd |
| CY2024Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
717000 | usd |
| us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
225000 | usd | |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
4343000 | usd | |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
3058000 | usd | |
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-85000 | usd | |
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-31000 | usd | |
| CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
165000 | usd |
| CY2023Q2 | us-gaap |
Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
199000 | usd |
| us-gaap |
Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
523000 | usd | |
| us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
0 | usd | |
| us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
229000 | usd | |
| CY2024Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
21315046 | shares |
| CY2024Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
21315046 | shares |
| CY2023Q2 | us-gaap |
Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
|
271000 | usd |
| CY2023Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1016000 | usd |
| CY2023Q2 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
172000 | usd |
| CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
435000 | usd |
| CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
49956000 | usd |
| CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
52276000 | usd |
| CY2024Q2 | us-gaap |
Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
|
39000 | usd |
| CY2024Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
998000 | usd |
| CY2024Q2 | us-gaap |
Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
|
283000 | usd |
| CY2024Q2 | us-gaap |
Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
259000 | usd |
| CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
53487000 | usd |
| CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
48003000 | usd |
| us-gaap |
Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
|
586000 | usd | |
| us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1736000 | usd | |
| us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
|
243000 | usd | |
| us-gaap |
Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
|
153000 | usd | |
| us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-47000 | usd | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
111000 | usd | |
| CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
49956000 | usd |
| CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
52302000 | usd |
| us-gaap |
Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
|
39000 | usd | |
| us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
2055000 | usd | |
| us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
|
186000 | usd | |
| us-gaap |
Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
|
283000 | usd | |
| us-gaap |
Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
624000 | usd | |
| us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
207000 | usd | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-395000 | usd | |
| CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
53487000 | usd |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-395000 | usd | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
111000 | usd | |
| us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
-194000 | usd | |
| us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
47000 | usd | |
| us-gaap |
Depreciation
Depreciation
|
5438000 | usd | |
| us-gaap |
Depreciation
Depreciation
|
5801000 | usd | |
| us-gaap |
Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
316000 | usd | |
| us-gaap |
Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
828000 | usd | |
| us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
1036000 | usd | |
| us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
1402000 | usd | |
| us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
495000 | usd | |
| us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
495000 | usd | |
| us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
39000 | usd | |
| us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
78000 | usd | |
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2055000 | usd | |
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1736000 | usd | |
| us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
405000 | usd | |
| us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-106000 | usd | |
| us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
1203000 | usd | |
| us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
506000 | usd | |
| us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
437000 | usd | |
| us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
885000 | usd | |
| us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
446000 | usd | |
| us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
994000 | usd | |
| us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
-914000 | usd | |
| us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
1719000 | usd | |
| us-gaap |
Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
|
-3265000 | usd | |
| us-gaap |
Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
|
-1183000 | usd | |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
2686000 | usd | |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
2301000 | usd | |
| infu |
Payments To Acquire Medical Equipment
PaymentsToAcquireMedicalEquipment
|
8796000 | usd | |
| infu |
Payments To Acquire Medical Equipment
PaymentsToAcquireMedicalEquipment
|
6994000 | usd | |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
519000 | usd | |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
494000 | usd | |
| us-gaap |
Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
|
2201000 | usd | |
| us-gaap |
Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
|
2098000 | usd | |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-7114000 | usd | |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-5390000 | usd | |
| us-gaap |
Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
|
26744000 | usd | |
| us-gaap |
Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
|
29451000 | usd | |
| us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
31769000 | usd | |
| us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
32585000 | usd | |
| us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
283000 | usd | |
| us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
153000 | usd | |
| us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
624000 | usd | |
| us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
523000 | usd | |
| us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
829000 | usd | |
| CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
231000 | usd |
| us-gaap |
Basis Of Accounting
BasisOfAccounting
|
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt">Basis of Presentation, Nature of Operations and Summary of Significant Accounting Policies</span><div style="margin-top:12pt;padding-right:7.2pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms "InfuSystem", the "Company", "we", "our" and "us" are used herein to refer to InfuSystem Holdings, Inc. and its subsidiaries. InfuSystem is a leading provider of infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers, and other sites of care. The Company provides products and services to hospitals, oncology practices and facilities and other alternative site health care providers. Headquartered in Rochester Hills, Michigan, the Company delivers local, field-based customer support, and also operates pump service and repair Centers of Excellence in Michigan, Kansas, California, Massachusetts, Texas and Ontario, Canada. The Company operates in two reportable segments, Patient Services and Device Solutions. During the fiscal year ended December 31, 2023, the Company also operated through First Biomedical, Inc., a Kansas Corporation, which was a wholly-owned subsidiary that merged into InfuSystem, Inc. on January 1, 2024.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") for interim financial information. Accordingly, the unaudited condensed consolidated financial statements do not include all of the information and notes required by U.S. Generally Accepted Accounting Principles ("GAAP") for complete financial statements. The accompanying unaudited condensed consolidated financial statements include all adjustments, composed of normal recurring adjustments, considered necessary by management to fairly state the Company’s results of operations, financial position and cash flows. The operating results for the interim periods are not necessarily indicative of results that may be expected for any other interim period or for the full year. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 as filed with the SEC on April 10, 2024.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements are prepared in conformity with GAAP, which requires the use of estimates, judgments and assumptions that affect the amounts of assets and liabilities at the reporting date and the amounts of revenue and expenses in the periods presented. The Company believes that the accounting estimates employed are appropriate and the resulting balances are reasonable; however, due to the inherent uncertainties in making estimates, actual results could differ from the original estimates, requiring adjustments to these balances in future periods.</span></div> | ||
| us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
2 | segment | |
| us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
2 | segment | |
| CY2024Q2 | us-gaap |
Revenues
Revenues
|
33698000 | usd |
| us-gaap |
Revenues
Revenues
|
65693000 | usd | |
| CY2024Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
21325000 | usd |
| CY2023Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
19830000 | usd |
| CY2024Q2 | infu |
Contract Assets
ContractAssets
|
1271000 | usd |
| CY2023Q4 | infu |
Contract Assets
ContractAssets
|
1271000 | usd |
| infu |
Contract Assets Revenue Recognized
ContractAssetsRevenueRecognized
|
5600000 | usd | |
| infu |
Contract Assets Revenue Partially Offset Amount
ContractAssetsRevenuePartiallyOffsetAmount
|
5600000 | usd | |
| CY2024Q2 | infu |
Medical Equipment Held For Sale Or Rental Gross
MedicalEquipmentHeldForSaleOrRentalGross
|
7007000 | usd |
| CY2023Q4 | infu |
Medical Equipment Held For Sale Or Rental Gross
MedicalEquipmentHeldForSaleOrRentalGross
|
3081000 | usd |
| CY2024Q2 | infu |
Medical Equipment For Sale Or Rental Reserve
MedicalEquipmentForSaleOrRentalReserve
|
27000 | usd |
| CY2023Q4 | infu |
Medical Equipment For Sale Or Rental Reserve
MedicalEquipmentForSaleOrRentalReserve
|
32000 | usd |
| CY2024Q2 | infu |
Medical Equipment Held For Sale Or Rental
MedicalEquipmentHeldForSaleOrRental
|
6980000 | usd |
| CY2023Q4 | infu |
Medical Equipment Held For Sale Or Rental
MedicalEquipmentHeldForSaleOrRental
|
3049000 | usd |
| CY2024Q2 | infu |
Medical Equipment In Rental Services Gross
MedicalEquipmentInRentalServicesGross
|
101398000 | usd |
| CY2023Q4 | infu |
Medical Equipment In Rental Services Gross
MedicalEquipmentInRentalServicesGross
|
96298000 | usd |
| CY2024Q2 | infu |
Medical Equipment In Rental Services Reserve
MedicalEquipmentInRentalServicesReserve
|
2239000 | usd |
| CY2023Q4 | infu |
Medical Equipment In Rental Services Reserve
MedicalEquipmentInRentalServicesReserve
|
2126000 | usd |
| CY2024Q2 | infu |
Medical Equipment In Rental Services Accumulated Depreciation
MedicalEquipmentInRentalServicesAccumulatedDepreciation
|
62897000 | usd |
| CY2023Q4 | infu |
Medical Equipment In Rental Services Accumulated Depreciation
MedicalEquipmentInRentalServicesAccumulatedDepreciation
|
59244000 | usd |
| CY2024Q2 | infu |
Medical Equipment In Rental Service Net Of Accumulated Depreciation
MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation
|
36262000 | usd |
| CY2023Q4 | infu |
Medical Equipment In Rental Service Net Of Accumulated Depreciation
MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation
|
34928000 | usd |
| CY2024Q2 | infu |
Medical Equipment Net
MedicalEquipmentNet
|
43242000 | usd |
| CY2023Q4 | infu |
Medical Equipment Net
MedicalEquipmentNet
|
37977000 | usd |
| CY2024Q2 | infu |
Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
|
2500000 | usd |
| infu |
Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
|
4800000 | usd | |
| us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
3100000 | usd | |
| us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
1600000 | usd | |
| CY2024Q2 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
10694000 | usd |
| CY2024Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
6520000 | usd |
| CY2024Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
4174000 | usd |
| CY2023Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
10268000 | usd |
| CY2023Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
5947000 | usd |
| CY2023Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
4321000 | usd |
| CY2024Q2 | us-gaap |
Depreciation Nonproduction
DepreciationNonproduction
|
300000 | usd |
| us-gaap |
Depreciation Nonproduction
DepreciationNonproduction
|
600000 | usd | |
| CY2024Q2 | us-gaap |
Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
|
2000000 | usd |
| CY2024Q2 | us-gaap |
Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
|
2000000 | usd |
| CY2024Q2 | us-gaap |
Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
|
52572000 | usd |
| CY2024Q2 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
45621000 | usd |
| CY2024Q2 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
6951000 | usd |
| CY2023Q4 | us-gaap |
Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
|
52572000 | usd |
| CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
45126000 | usd |
| CY2023Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
7446000 | usd |
| CY2023Q2 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
200000 | usd |
| CY2024Q2 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
200000 | usd |
| CY2024Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
|
495000 | usd |
| CY2024Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
810000 | usd |
| CY2024Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
525000 | usd |
| CY2024Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
471000 | usd |
| CY2024Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
348000 | usd |
| CY2024Q2 | infu |
Amortization Expense Year Five And Thereafter
AmortizationExpenseYearFiveAndThereafter
|
2302000 | usd |
| CY2024Q2 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
4951000 | usd |
| CY2024Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
|
0 | usd |
| CY2024Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
|
0 | usd |
| CY2024Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
|
0 | usd |
| CY2024Q2 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
|
0 | usd |
| CY2024Q2 | infu |
Long Term Debt Maturities Repayments Of Principal Year Four And Thereafter
LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereafter
|
34464000 | usd |
| CY2024Q2 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
34464000 | usd |
| CY2024Q2 | infu |
Unamortized Debt Issuance Expense Current
UnamortizedDebtIssuanceExpenseCurrent
|
0 | usd |
| CY2024Q2 | infu |
Unamortized Debt Issuance Expense Noncurrent
UnamortizedDebtIssuanceExpenseNoncurrent
|
299000 | usd |
| CY2024Q2 | us-gaap |
Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
|
299000 | usd |
| CY2023Q4 | infu |
Unamortized Debt Issuance Expense Current
UnamortizedDebtIssuanceExpenseCurrent
|
0 | usd |
| CY2023Q4 | infu |
Unamortized Debt Issuance Expense Noncurrent
UnamortizedDebtIssuanceExpenseNoncurrent
|
338000 | usd |
| CY2023Q4 | us-gaap |
Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
|
338000 | usd |
| CY2024Q2 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
0 | usd |
| CY2024Q2 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
34165000 | usd |
| CY2024Q2 | us-gaap |
Long Term Debt
LongTermDebt
|
34165000 | usd |
| CY2023Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
0 | usd |
| CY2023Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
29101000 | usd |
| CY2023Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
29101000 | usd |
| CY2024Q2 | us-gaap |
Interest Expense Nonoperating
InterestExpenseNonoperating
|
500000 | usd |
| CY2023Q2 | us-gaap |
Interest Expense Nonoperating
InterestExpenseNonoperating
|
600000 | usd |
| us-gaap |
Interest Expense Nonoperating
InterestExpenseNonoperating
|
900000 | usd | |
| us-gaap |
Interest Expense Nonoperating
InterestExpenseNonoperating
|
1100000 | usd | |
| CY2024Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
600000 | usd |
| CY2023Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
200000 | usd |
| CY2024Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
1300000 | usd |
| CY2023Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
600000 | usd |
| CY2024Q2 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.452 | |
| CY2023Q2 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.309 | |
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
400000 | usd | |
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-100000 | usd | |
| CY2024Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
717000 | usd |
| CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
435000 | usd |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-395000 | usd | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
111000 | usd | |
| CY2024Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
21299089 | shares |
| CY2023Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
20955048 | shares |
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
21262429 | shares | |
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
20904315 | shares | |
| CY2024Q2 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
412109 | shares |
| CY2023Q2 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
645298 | shares |
| us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
0 | shares | |
| us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
661352 | shares | |
| CY2024Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
21711198 | shares |
| CY2023Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
21600346 | shares |
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
21262429 | shares | |
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
21565667 | shares | |
| CY2024Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.03 | |
| CY2023Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.02 | |
| us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.02 | ||
| us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.01 | ||
| CY2024Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.03 | |
| CY2023Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.02 | |
| us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.02 | ||
| us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.01 | ||
| CY2024Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
1917188 | shares |
| CY2023Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
901995 | shares |
| us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
2530571 | shares | |
| us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
755234 | shares | |
| CY2024Q2 | srt |
Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
|
20000000.0 | usd |
| CY2024Q2 | infu |
Share Repurchase Program Cumulative Shares Repurchased
ShareRepurchaseProgramCumulativeSharesRepurchased
|
300000 | usd |
| CY2024Q2 | infu |
Share Repurchase Program Cumulative Shares Purchased Shares
ShareRepurchaseProgramCumulativeSharesPurchasedShares
|
41139 | shares |
| CY2024Q2 | infu |
Share Repurchase Program Cumulative Shares Repurchased
ShareRepurchaseProgramCumulativeSharesRepurchased
|
6200000 | usd |
| CY2024Q2 | infu |
Share Repurchase Program Cumulative Shares Purchased Shares
ShareRepurchaseProgramCumulativeSharesPurchasedShares
|
553149 | shares |
| CY2024Q2 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
| CY2024Q2 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
| CY2024Q2 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false |
